The customer stated that they received erroneous results for one patient sample tested for d-di tina-quant d-dimer gen.2 (ddi) on a cobas 6000 c (501) module - c501.The erroneous results were reported outside of the laboratory to a doctor.The sample initially resulted with a ddi value of 3.34 mg/l feu accompanied by a data flag.The sample was automatically repeated, resulting as 3.33 mg/l feu accompanied by a data flag.The patient was sent to the hospital based on the c501 value.At the hospital, the patient was tested for ddi using sysmex analyzer which used siemens reagent.The result from the sysmex analyzer was normal, so no treatment was provided.On (b)(6) 2018, the sample was repeated on the c501 analyzer, resulting as 3.31 mg/l feu accompanied by a data flag.The sample was automatically repeated, resulting as 3.33 mg/l feu accompanied by a data flag.The sample was sent to another laboratory where it was measured using the same type of analyzers.On a second c501 analyzer at the other site, the sample resulted as 3.58 mg/l feu.On a sysmex analyzer at the other site, the sample resulted with a value that was under the limit of detection.No adverse events were alleged to have occurred with the patient.The c501 analyzer serial number was (b)(4).
|
Upon review of the calibration data, frequent calibration failures were observed.Quality controls were within range on (b)(6) 2018.Quality control recovery was generally good.Abnormal probe aspiration alarms occurred on (b)(6) 2018.Reagent warning level alarms occurred on (b)(6) 2018.Further investigation of the sample showed decreasing ddi results when the sample was diluted.This indicates interference.The igm result was also above the normal range, which could indicate a gammopathy interference.Product labeling lists immunoglobulin interference as a potential limitation of the assay.Sample measurements did not indicate an interference by rheumatoid factors or fibrinogen.
|